H NMR, 13 C NMR, 2D NMR data of and 2 and GC-MS data of mixtures A and B (see below).
Bioactivity screening data of T. blumei extract and fractions (see below). Table S1 . Anti-allergic data of fatty acids (1 -1000 µM). Please see attached xlsx. file. a Platelets were incubated with samples (50 µg/ml) or with vehicle for 3 min, followed by the addition of platelet inducers, collagen (10 µg/ml) or thrombin (0.05 U/ml). Results are expressed as percent inhibition of platelet aggregation (n = 1); compared with the control value (collagen or thrombin). Active fractions are indicated by red color. a Anti-inflammatory activity was evaluated by superoxide anion generation and elastase release assays in human neutrophils using fMLF/CB as inducer. Percent inhibition; results are presented as mean ± SEM (n = 3 -4); compared with the control value (fMLF/CB). Active fractions are indicated by red color. 6.4 ± 0.9 TB-RE subfraction 8 TB-8 4.3 ± 0.6 2.4 ± 0.5 TB-RE subfraction 9 TB-9 1.5 ± 0.2 1.3 ± 0.1 TB-RE subfraction 10 TB-10 2.5 ± 0.6 1.9 ± 0.6 TB-RE subfraction 11 TB-11 2.6 ± 0.6 1.6 ± 0.3 TB-RE subfraction 12 TB-12 >10 f 4.2 ± 1.2 TB-RE subfraction 13 TB-13 6.5 ± 1.8 2.3 ± 0.6 a Anti-inflammatory capacity was evaluated by superoxide anion generation and elastase release assays in human neutrophils using fMLF/CB as inducer. IC 50 values; results are presented as mean ± SEM (n = 3 -4); compared with the control value (fMLF/CB).
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b IC 50 values express the concentration of the sample required to inhibit superoxide anion generation or elastase release by 50%. c TB-5 exerted significant inhibitory activity in elastase release (22.9 ±5.6%) assay at 10 µM.
d TB-6 exerted significant inhibitory activity in superoxide anion generation (23.2 ± 3.7%) assay at 10 µM.
e TB-7 exerted significant inhibitory activity in superoxide anion generation (39.4 ± 1.3%) assay at 10 µM.
f TB-12 exerted significant inhibitory activity in superoxide anion generation (14.8 ± 1.4%) assay at 10 µM. a The cytotoxicity of samples to RBL-2H3 was evaluated using MTT viability assay and the toxic concentrations are labelled as 'TOXIC' (viability less than 80%). The inhibition of degranulation was assessed by A23187-induced β-hexosaminidase release in RBL-2H3 cells; percent inhibition; results are presented as mean (n = 3); compared with the control value (A23187). -not active (insignificant inhibition of degranulation, below 20%)
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